PRME
Prime Medicine, Inc.
+0.23 (+7.83%)3.24USD1.5M成交股數587M市值–本益比(近四季)126.7股價營收比–營收年增(近四季)2026-11-06下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | 838K+301% | 1.2M | 1.1M+89% | 1.5M | 209K | 0.00 | 591K | 0.00 | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 33.4M | 34.1M | 34.7M | 44.0M | 41.4M | 40.6M | 40.3M | 43.1M | 37.8M | 41.5M | 41.0M | 34.6M |
| 銷售管理費用 | 11.0M | 17.4M | 14.7M | 11.2M | 13.1M | 13.3M | 14.1M | 12.6M | 11.2M | 13.1M | 10.5M | 10.7M |
| 營業利益 | −43.3M-19% | −50.7M-3% | −48.6M-10% | −54.0M-3% | −53.4M+10% | −52.4M-23% | −54.2M+5% | −55.7M+23% | −48.3M | −68.0M | −51.5M | −45.3M |
| 營業利益率 | – | – | -5,800.5% | -4,406.0% | -4,787.2% | -3,603.3% | -25,948.3% | – | -8,179.5% | – | – | – |
| 稅後淨利 | −42.1M-20% | −49.1M-5% | −46.1M-12% | −50.6M-9% | −52.6M+15% | −51.9M-21% | −52.5M+4% | −55.3M+31% | −45.8M | −65.6M | −50.7M | −42.4M |
| 淨利率 | – | – | -5,498.7% | -4,129.1% | -4,716.7% | -3,568.8% | -25,128.2% | – | -7,743.0% | – | – | – |
| 稀釋 EPS | -0.24-41% | -0.28-30% | -0.22-50% | -0.32-30% | -0.41-7% | -0.40-44% | -0.44-20% | -0.46-2% | -0.44 | -0.72 | -0.55 | -0.47 |
| 稀釋股數 | 177M | 177M | 149M | 161M | 129M | 131M | 120M | 119M | 104M | 91.0M | 91.8M | 90.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 47.5M | 64.1M | 63.0M | 71.4M | 53.8M | 91.9M | 118M | 55.6M | 94.2M | 41.6M | 44.0M | 121M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 249M | 295M | 343M | 385M | 279M | 328M | 333M | 260M | 311M | 194M | 239M | 281M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 209M | 218M | 222M | 223M | 218M | 221M | 143M | 63.1M | 67.6M | 60.8M | 45.2M | 40.8M |
| 股東權益 | 39.8M | 76.7M | 121M | 162M | 60.9M | 107M | 190M | 197M | 244M | 133M | 194M | 240M |
| 負債比 | 84.0% | 74.0% | 64.7% | 58.0% | 78.2% | 67.4% | 43.1% | 24.3% | 21.7% | 31.4% | 18.9% | 14.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −42.7M-13% | – | – | – | −48.9M | – | – | −67.7M | – | – | – |
| 資本支出 | – | 214K | – | – | – | 2.4M | – | – | 2.3M | – | – | – |
| 自由現金流 | – | −42.9M-16% | – | – | – | −51.3M | – | – | −70.0M | – | – | – |
| 折舊攤銷 | 1.8M | 1.9M | 1.9M | 1.9M | 1.9M | 1.7M | 1.6M | 1.5M | 1.3M | 1.2M | 1.2M | 1.1M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | -3,526.8% | – | – | -11,849.6% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 4.6M
| Reportable | 4.6M | 100.0% | +55.3% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 4.6M | +55.3% | −201M | -4,342.4% | -1.35 | −167M |
| FY2024 | 3.0M | – | −196M | -6,566.6% | -1.65 | −130M |
| FY2023 | 0.00 | – | −198M | –% | -2.18 | −174M |
| FY2022 | 0.00 | – | −122M | –% | -4.19 | −148M |
| FY2021 | 0.00 | -100.0% | −165M | –% | -14.19 | −38.2M |
| FY2020 | 5.2M | – | −3.4M | -65.5% | -1.91 | −6.2M |